Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Share-based Compensation (2016 - 2026)

Summit Therapeutics filings provide 12 years of Share-based Compensation readings, the most recent being $72.8 million for Q1 2026.

  • Quarterly Share-based Compensation rose 556.01% to $72.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $794.1 million through Mar 2026, up 1410.59% year-over-year, with the annual reading at $732.4 million for FY2025, 1336.65% up from the prior year.
  • Share-based Compensation hit $72.8 million in Q1 2026 for Summit Therapeutics, down from $111.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $478.8 million in Q2 2025 and bottomed at $705000.0 in Q3 2023.
  • Average Share-based Compensation over 5 years is $51.9 million, with a median of $9.5 million recorded in 2024.
  • The largest annual shift saw Share-based Compensation tumbled 74.8% in 2023 before it soared 4218.04% in 2025.
  • Summit Therapeutics' Share-based Compensation stood at $2.7 million in 2022, then surged by 229.31% to $8.8 million in 2023, then rose by 25.84% to $11.0 million in 2024, then soared by 914.79% to $111.8 million in 2025, then plummeted by 34.88% to $72.8 million in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Share-based Compensation are $72.8 million (Q1 2026), $111.8 million (Q4 2025), and $130.8 million (Q3 2025).